Skip to main content

  • Novel Monoclonal Antibody Slashes Cholesterol in HoFH

    • Posted: 08/14/2019
    • Author:

      Nicole Lou, Contributing Writer, MedPage Today

    • 2019News Articles

    IV drug shines in familial hypercholesterolemia atop other lipid agents

    Novel agent evinacumab nearly halves LDL cholesterol in homozygous familial hypercholesterolemia (HoFH) atop even a PCSK9 inhibitor, according to topline trial results announced by drugmaker Regeneron.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details